Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Chronic Cough Market From 2025 To 2029?

The market for chronic cough treatment has seen robust expansion recently, with predictions stating it will increase from $8.22 billion in 2024 to $8.87 billion in 2025, reflecting a compounded annual growth rate (CAGR) of 8.0%. This substantial growth in the past years can be attributed to several factors including the widespread prevalence of respiratory illnesses, environmental aspects, air pollution, tobacco consumption, respiratory infections, as well as allergies and sensitivities to the environment.

The market size of chronic cough is predicted to experience a robust expansion in the upcoming years, reaching$12.83 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.7%. The anticipated growth during the forecast period may be credited to new therapy options targeting specific pathways, an enhanced understanding of reflux-induced cough, global initiatives to quit smoking, and the implementation of environmental and occupational health policies. The forecast period is expected to witness significant trends like the progression in diagnostic technologies, patient-oriented strategies, novel therapies for neurogenic cough, the use of telehealth for managing chronic cough, and research into central sensitization.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

Which Factors and External Forces Are Driving Demand in the Chronic Cough Market?

The escalation in the occurrence of cough is predicted to boost the expansion of the chronic cough market. Cough is a reflex action, often in reaction to irritation, mucus or foreign objects, serving to maintain clear airways by forcefully expelling air from the lungs. A continual cough persisting for a minimum of eight weeks is deemed chronic. Thus, an increase in cough instances directly corresponds to a rise in chronic cough cases. For example, in March 2022, as per the Florida Health, a healthcare department based in the US, a total of 80 patients were diagnosed in 2021, with rates of 41.0 and 1.4 per 100,000 years, respectively. In 2023, there were 28 registered pertussis cases across 13 countries. Moreover, in March 2022, the Statens Serum Institut, a Denmark-based disease surveillance department, reported a surge in pertussis cases by 41% from November 2022 to April 2023, as opposed to November 2021–April 2022, in Denmark. Hence, the increasing occurrence of cough is fueling the advancement of the chronic cough market.

Which Segments in the Chronic Cough Offer the Most Growth?

The chronic coughmarket covered in this report is segmented –

1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Combination Drug; Antibiotics; Acid Blockers; Other Drug Classes

2) By Route Of Administration: Oral; Inhalational; Injectable; Other Route Of Administrations

3) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

Subsegments:

1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines

2) By Corticosteroids: Inhaled Corticosteroids; Systemic Corticosteroids

3) By Decongestants: Oral Decongestants; Nasal Decongestants

4) By Combination Drug: Antihistamine And Decongestant Combinations; Cough Suppressant And Expectorant Combinations

5) By Antibiotics: Macrolides; Penicillins; Cephalosporins

6) By Acid Blockers: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists

7) By Other Drug Classes: Mucolytics; Cough Suppressants; Herbal Remedies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12109&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Chronic Cough Market?# Market?

North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theChronic Cough Market’s Growth?

Prominent firms in the chronic cough market are focusing on developing innovative offerings like biosimilars to solidify their market standing. These biosimilars are employed for treating ailments such as cancer, autoimmune diseases, and diabetes, thereby presenting a cost-efficient substitute to current biologics. For instance, in July 2024, Sandoz, a pharmaceutical company based in Switzerland, introduced its biosimilar product Pyzchiva (ustekinumab) throughout Europe, aimed at treating chronic inflammatory diseases like plaque psoriasis, psoriatic arthritis, and Crohn’s disease. Notably, this is the first biosimilar of its kind launched in Europe with all reference medicine strengths, including the initial dose for Crohn’s disease. Developed in collaboration with Samsung Bioepis, Sandoz’s goal is to widen the reach of effective treatments to the millions dealing with these diseases. This introduction is a testament to Sandoz’s dedication to deliver budget-friendly healthcare solutions and enhance the life quality of patients throughout Europe.

View the full report here:

https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

What Are the Key Elements That Define the Chronic Cough Market?

Chronic cough refers to a cough that is persistent and lasts for a long time, usually eight weeks or more. It frequently manifests as signs of an underlying illness, such as asthma, allergies, or respiratory infections.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12109

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model